Series C funding
3 stories filed under Series C funding on Beyond Market Intelligence. The newest of them: “Isomorphic Labs secures $5B to accelerate AI-designed drugs into trials”, “SiMa.ai secures $150M to bring physical AI chips beyond the data center”, and “Wonderful secures $550M to accelerate product development and meet growing demand”. Isomorphic Labs just raised $5 billion to push AI-designed drugs into clinical trials, and that number should make you pause. SiMa.ai just closed a $150 million Series C from Fidelity and Amplify, betting that physical AI demands chips designed for the edge, not the data center. Acme AI is the next-generation, AI-powered spreadsheet platform built to replace Excel and redefine how analysts, data scientists, and enterprise teams work… The list below is every Series C funding story on Beyond Market Intelligence, newest first.

Isomorphic Labs secures $5B to accelerate AI-designed drugs into trials
Isomorphic Labs just raised $5 billion to push AI-designed drugs into clinical trials, and that number should make you pause. Spun out of Google's DeepMind in 2021, the company is betting that machine learning can discover molecules faster than traditional labs ever could. This isn't hype, it's a concrete signal that AI is ready to move from theory to patient impact.

SiMa.ai secures $150M to bring physical AI chips beyond the data center
SiMa.ai just closed a $150 million Series C from Fidelity and Amplify, betting that physical AI demands chips designed for the edge, not the data center. That's a smart wager. The company's focus on bringing intelligence to where data actually lives, sensors, machines, devices, feels more grounded than chasing distant cloud promises. For deeper context on how hardware and AI design choices are diverging, our piece on neural architecture search offers useful perspective.

Wonderful secures $550M to accelerate product development and meet growing demand
Wonderful just closed a $550 million Series C that more than doubles its valuation to $5B in under six months. That kind of acceleration signals real market appetite, not hype. The company plans to channel the funding into faster product development, expanding its FDE teams, and keeping up with demand. It's a decisive move for a team clearly focused on scale. For context on how AI-native momentum is reshaping investment, our piece on the $5.75B surge in AI-native companies is worth a look.